Presentation is loading. Please wait.

Presentation is loading. Please wait.

Variable levels of cell surface and intracellular marker expression by HuT78 and HuT102 cells. Variable levels of cell surface and intracellular marker.

Published byYuliana Sugiarto Modified over 5 years ago

Similar presentations

Presentation on theme: "Variable levels of cell surface and intracellular marker expression by HuT78 and HuT102 cells. Variable levels of cell surface and intracellular marker."— Presentation transcript:

1 Variable levels of cell surface and intracellular marker expression by HuT78 and HuT102 cells.
Variable levels of cell surface and intracellular marker expression by HuT78 and HuT102 cells. (A) Hut78 and (B) HuT102 cells were maintained in cRPMI until harvest followed by staining for flow cytometry assay using specific Abs for the indicated cell surface and intracellular markers. Dead cells were eliminated from analysis based on their loss of membrane integrity and, thus, inclusion of a dead cell dye. The data shown represent live HuT cells on dot plots and histograms. On histograms, the levels of specific marker’s expression are shown in black line with transparent background, whereas an individual for each marker isotype control Ab stain is shown in solid gray color. The flow cytometry analysis data of one out of three experiments are shown. Svetlana P. Chapoval et al. ImmunoHorizons 2019;3:71-87 Copyright © 2019 by The Authors

Download ppt "Variable levels of cell surface and intracellular marker expression by HuT78 and HuT102 cells. Variable levels of cell surface and intracellular marker."

Similar presentations

A. a). d). c). f). b).e). g). Figure S1. NAT2 expression in lymphocytes and monocytes from a healthy volunteer. PBMC from a healthy volunteer were simple.

A. a). d). c). f). b).e). g). Figure S1. NAT2 expression in lymphocytes and monocytes from a healthy volunteer. PBMC from a healthy volunteer were simple.
From: Neurokinin-1 Receptor Antagonists Inhibit the Recruitment of Opioid-containing Leukocytes and Impair Peripheral Antinociception Anesthes. 2007;107(6):1009-1017.

From: Neurokinin-1 Receptor Antagonists Inhibit the Recruitment of Opioid-containing Leukocytes and Impair Peripheral Antinociception Anesthes. 2007;107(6):
Chemokine Receptor Expression on Neoplastic and Reactive T Cells in the Skin at Different Stages of Mycosis Fungoides  Tilmann Kallinich, J. Marcus Muche,

Chemokine Receptor Expression on Neoplastic and Reactive T Cells in the Skin at Different Stages of Mycosis Fungoides  Tilmann Kallinich, J. Marcus Muche,
Anti-CD40 and CpG induce activation of T cells in draining lymph nodes

Anti-CD40 and CpG induce activation of T cells in draining lymph nodes
Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.

Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.
Melanoma donor (MD) NK cells are functionally impaired/exhausted.

Melanoma donor (MD) NK cells are functionally impaired/exhausted.
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)‏

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)‏
Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25 cells. Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25.

Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25 cells. Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25.
Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs

Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong

by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
Depletion of CD169+ cells leads to increased expression of CD25 on enterotoxin A–specific Vβ3+ T cells. Depletion of CD169+ cells leads to increased expression.

Depletion of CD169+ cells leads to increased expression of CD25 on enterotoxin A–specific Vβ3+ T cells. Depletion of CD169+ cells leads to increased expression.
Depo-Provera altered the expression of cell surface markers associated with HIV susceptibility. Depo-Provera altered the expression of cell surface markers.

Depo-Provera altered the expression of cell surface markers associated with HIV susceptibility. Depo-Provera altered the expression of cell surface markers.
Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155  Naomi Takahashi,

Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155  Naomi Takahashi,
rSema4A potentiates Treg cells in CD4+ T cell cultures.

rSema4A potentiates Treg cells in CD4+ T cell cultures.
Exposure to rSema4A increases Treg cell numbers in human PBMC in vitro cultures. Exposure to rSema4A increases Treg cell numbers in human PBMC in vitro.

Exposure to rSema4A increases Treg cell numbers in human PBMC in vitro cultures. Exposure to rSema4A increases Treg cell numbers in human PBMC in vitro.
Blocking of Plexin B1 before rSema4A applications decreases the relative numbers of Treg cells and IL-2 secretion in human PBMCs. Human anti–Plexin B1.

Blocking of Plexin B1 before rSema4A applications decreases the relative numbers of Treg cells and IL-2 secretion in human PBMCs. Human anti–Plexin B1.
Human Treg cells express PlexinB1.

Human Treg cells express PlexinB1.
rSema4A increases the relative number of CD4+CD25+ HuT cells.

rSema4A increases the relative number of CD4+CD25+ HuT cells.
rSema4A induces iTreg cells in CD4+ T cell cultures.

rSema4A induces iTreg cells in CD4+ T cell cultures.
Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.

Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.

Similar presentations

Ads by Google